Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 241.20
+1.30 (0.54%)
Oct 29, 2025, 9:29 AM IST
Hikal Employees
Hikal had 2,062 employees as of March 31, 2025. The number of employees increased by 1 or 0.05% compared to the previous year.
Employees
2,062
Change (1Y)
1
Growth (1Y)
0.05%
Revenue / Employee
8.89M INR
Profits / Employee
306.98K INR
Market Cap
29.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2,062 | 1 | 0.05% |
| Mar 31, 2024 | 2,061 | -81 | -3.78% |
| Mar 31, 2023 | 2,142 | 236 | 12.38% |
| Mar 31, 2022 | 1,906 | 378 | 24.74% |
| Mar 31, 2021 | 1,528 | -101 | -6.20% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Hikal News
- 5 weeks ago - Baba Kalyani's son retains Hikal board seat amid feud - The Times of India
- 2 months ago - Hikal shares fall over 2% after US FDA issues warning letter for Jigani facility - Business Upturn
- 2 months ago - Hikal receives warning letter from US FDA for Jigani facility - Business Upturn
- 2 months ago - Hikal shares fall nearly 7% after Q1 loss of Rs 22.4 crore - Business Upturn
- 2 months ago - Hikal reports Q1 net loss of Rs 22.4 crore; revenue declines 6.5% YoY - Business Upturn
- 4 months ago - Hikal successfully clears ANVISA GMP audit for Bengaluru API manufacturing facility - Business Upturn
- 5 months ago - Hikal receives OAI classification from US FDA for Jigani facility - Business Upturn
- 5 months ago - Hikal share price jumps 4% as Q4 revenue rises 7.4% YoY to Rs 552 crore, net profit up 48% YoY - Business Upturn